Patents by Inventor Brian L. Pipes

Brian L. Pipes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Stem Cell Fusion Model of Carcinogenesis
    Publication number: 20140308297
    Abstract: Model systems and methods for exploring mechanisms of carcinogenesis and the acquisition of metastatic ability, and to provide insights into potential therapeutic targets. The systems include and methods involve fusion of a stem cell and a genetically altered cell to evaluate carcinogenesis and metastasis and for the discovery and evaluation of new therapeutic targets to inhibit metastasis and other markers of carcinogenesis.
    Type: Application
    Filed: June 25, 2014
    Publication date: October 16, 2014
    Applicant: Arizona Board of Regents on behalf of the University of Arizona
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Michael E. Pennington, Linda C. Meade-Tollin
  • Stem cell fusion model of carcinogenesis
    Patent number: 8758755
    Abstract: Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell. Antibodies against ubiquitin are shown to inhibit tumor cell migration.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: June 24, 2014
    Assignee: Arizona Board of Regents on behalf of the University of Arizona
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Linda C. Meade-Tollin
  • Stem Cell Fusion Model of Carcinogenesis
    Publication number: 20120295344
    Abstract: Model systems and methods for exploring mechanisms of carcinogenesis and the acquisition of metastatic ability, and to provide insights into potential therapeutic targets. The systems include and methods involve fusion of a stem cell and a genetically altered cell to evaluate carcinogenesis and metastasis and for the discovery and evaluation of new therapeutic targets to inhibit metastasis and other markers of carcinogenesis.
    Type: Application
    Filed: April 16, 2012
    Publication date: November 22, 2012
    Applicant: Arizona Board of Regents on behalf of the University of Arizona
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Michael E. Pennington, Linda C. Meade-Tollin
  • Stem Cell Fusion Model of Carcinogenesis
    Publication number: 20120201808
    Abstract: Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell. Antibodies against ubiquitin are shown to inhibit tumor cell migration.
    Type: Application
    Filed: April 16, 2012
    Publication date: August 9, 2012
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Linda C. Meade-Tollin
  • Stem cell fusion model of carcinogenesis
    Patent number: 8158126
    Abstract: Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell (FIG. 1). Antibodies against ubiquitin are shown to inhibit tumor cell migration.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: April 17, 2012
    Assignee: Arizona Board of Regents on Behalf of The University of Arizona
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Linda C. Meade-Tollin
  • Stem Cell Fusion Model of Carcinogenesis
    Publication number: 20090016961
    Abstract: Methods for modeling cancer cell migration, screening drugs for effects on tumor cell migration, and detecting the potential for tumor cell migration relating to the fusion of a bone marrow derived stem cell with a genetically altered cell (FIG. 1). Antibodies against ubiquitin are shown to inhibit tumor cell migration.
    Type: Application
    Filed: August 25, 2006
    Publication date: January 15, 2009
    Inventors: David T. Harris, Tom C. Tsang, Xianghui He, Brian L. Pipes, Linda C. Meade-Tollin